Rapid Communications |
Subunit
From the Departments of Molecular Biology and Pharmacology (D.M.B., H.X., J.M.N.) and Surgery (R.B.S.), Washington University Medical School, St Louis, Mo.
Correspondence to Dr Jeanne M. Nerbonne, Department of Molecular Biology and Pharmacology, Washington University Medical School, 660 South Euclid Ave, St Louis, MO 63110. E-mail jnerbonn{at}pharmdec.wustl.edu
| Abstract |
|---|
|
|
|---|
subunit, was
developed and exploited to probe the molecular identity of the cardiac
transient outward K+ current
(Ito). A point mutation (W to F) was
introduced at position 362 in the pore region of Kv4.2 to produce a
nonconducting mutant (Kv4.2W362F) subunit. Coexpression of Kv4.2W362F
with Kv4.2 (or Kv4.3) attenuates the wild-type currents, and the effect
is subfamily specific; ie, Kv4.2W362F does not affect heterologously
expressed Kv1.4 currents. With the use of the
-myosin heavy chain
promoter to direct cardiac-specific expression, several lines of
Kv4.2W362F transgenic mice were generated.
Electrophysiological recordings reveal that
Ito is selectively eliminated in
ventricular myocytes isolated from transgenic mice
expressing Kv4.2W362F, thereby demonstrating directly that the Kv 4
subfamily underlies Ito in the mammalian
heart. Functional knockout of Ito leads to
marked increases in action potential durations in
ventricular myocytes and to prolongation of the QT interval
in surface ECG recordings. In addition, a novel rapidly
activating and inactivating K+ current, which is not
detectable in myocytes from nontransgenic littermates, is evident in
Kv4.2W362F-expressing ventricular cells. Importantly, these
results demonstrate that electrical remodeling occurs in the heart when
the expression of endogenous K+ channels
is altered.
Key Words: transgenic mouse transient outward current ventricle action potential long QT
| Introduction |
|---|
|
|
|---|
Recently, 2 K+ channel genes,
KvLQT17 and human ether-a-go-go (or
HERG)8 have been identified as the
loci of mutations in 2 forms of familial long-QT syndrome.
HERG underlies IKr (the rapid
IK) in cardiac
cells,9 10 whereas KvLQT1 contributes to
IKs (the slow
IK).11 12 In contrast
to the functional and molecular diversity of
IK, the properties of
Ito in adult mammalian cardiac cells
isolated from different species, as well as from different regions of
the heart in the same species, are quite similar, suggesting that the
molecular correlates of Ito in different
species and cell types are likely the same.1
Previous biochemical, molecular, and pharmacological studies have
suggested alternatively that members of the Shal (Kv
4)13 14 15 16 17 18 or the Shaker (Kv
1)19 20 subfamilies of voltage-gated
K+ channel (Kv)
subunits contribute to
Ito in mature myocardial cells.
The experiments in the present study were undertaken to test
directly the hypothesis that members of the Kv4 subfamily underlie
Ito in the mammalian heart and to determine
the physiological consequences of the functional
knockout of Ito on myocardial excitability.
To achieve this, a point mutation was introduced in the pore region of
Kv4.2 to produce a subunit (Kv4.2W362F) that functions as a dominant
negative.21 22 Transgenic mice expressing Kv4.2
driven by the
-myosin heavy chain
promoter23 24 25 26 were then generated and
characterized. Electrophysiological studies reveal
that Ito is selectively eliminated in
ventricular myocytes isolated from Kv4.2W362F-expressing
mice, demonstrating that the Kv4 subfamily underlies
Ito in the mammalian heart. In addition,
functional knockout of Ito leads to marked
increases in action potential durations in ventricular
myocytes and to prolongation of the QT interval.
| Materials and Methods |
|---|
|
|
|---|
Generation of Transgenic Mice Expressing
-MHCKv4.2W362F-FLAG
The Kv4.2W362F-FLAG coding sequence was subcloned into the
-myosin heavy chain (
-MHC) vector23 24 25 26 at
the SalI site. The
-MHCKv4.2W362F plasmid was digested
to isolate a 7-kb fragment that included the
-MHC promoter, the
first 3 noncoding exons of the
-MHC gene, the Kv4.2W362F-FLAG coding
sequence, and the human growth hormone (HGH) polyadenylation signal
sequences.23 24 25 26 After purification, this
fragment was resuspended in 100 µL of 10 mmol/L Tris buffer
containing 10 mmol/L NaCl and 0.1 mmol/L EDTA at pH 7.4 and
dialyzed against a 0.1-µm Millipore filter. The fragment was then
diluted to a concentration of 1 ng/µL and injected into 100
fertilized C57CBA mouse oocytes. After the injections, the oocytes were
transplanted into pseudopregnant C57CBA adult mice. A total of 57
offspring were obtained, and all were screened for expression of the
transgene by Southern blot analysis of (tail) genomic DNA; a
probe directed against the HGH polyadenylation sequence (in the
-MHC
vector2326) was used to assay for transgene
expression. Briefly, genomic DNA was isolated, digested with
EcoRI, and electrophoresed through a 1% agarose gel. The
gel was then treated sequentially with 0.25 mol/L HCl for 25 minutes,
denaturing buffer (0.5 mol/L NaOH and 1.5 mol/L NaCl) for 1 hour, and
then neutralization buffer (0.1 mol/L Tris containing 1.5 mol/L NaCl at
pH 7.5). The DNA was then transferred from the gel to Magnacharge nylon
membrane (MSI Separations), and the membranes were incubated with a
radiolabeled probe directed against the HGH polyadenylation sequences
overnight at 42°C. After repeated washings, the membranes were
exposed to film for 2 to 5 days at -80°C; the films were then
developed, and the 3 animals positive for the transgene were identified
(see Results).
Cell Lines and Transient Transfections
QT-6 cells (a quail fibroblast cell line), originally obtained
from the laboratory of Dr John Merlie (Washington University Medical
School, St Louis, Mo) and maintained as described
previously,14 were transiently transfected by the
calcium phosphate method14 with plasmids encoding
Kv4.2, Kv4.3, or Kv4.2W362F together with green fluorescent
protein (pGREENLANTERN, GIBCO BRL) to allow transfected cells to be
identified before electrophysiological
recordings.
Expression of Kv4.2W362F in Transgenic Mice
Ventricular myocytes were isolated from adult
transgenic and wild-type mice by use of a protocol similar to one
previously described for isolation of rat
cardiocytes.16 To assay FLAG expression,
cells were fixed in 4% paraformaldehyde in 0.1 mol/L
PBS at pH 7.4 for 1 hour. After a 1-hour incubation in blocking buffer
(PBS containing 5% normal goat serum, 0.2% Triton X-100, and 0.1%
NaN3), cells were incubated overnight at 4°C
with the anti-FLAG M2 antibody (Eastman Kodak) diluted 1:500 in
blocking buffer. After they were washed with PBS, cells were then
exposed for 1 hour at room temperature to a Cy3-conjugated goat
anti-mouse secondary antibody (Chemicon) diluted 1:1000 in blocking
buffer; labeling was visualized under epifluorescence
illumination.
Mouse ventricular membrane proteins were prepared using a protocol previously developed for the isolation of rat cardiac membrane proteins.14 16 After fractionation by SDS-PAGE and transfer to polyvinylidene fluoride membranes (Amersham), immunoblots were completed with the anti-FLAG M2 antibody diluted 1:500, followed by an alkaline phosphataseconjugated goat anti-mouse secondary antibody (Tropix). Bound antibodies were detected using the CPSD (Tropix) chemiluminescent alkaline phosphatase substrate.14 16
Electrophysiological Recordings
Whole-cell voltage-clamp recordings from green
fluorescent proteinpositive QT-6 cells were
obtained at room temperature
48 hours after transfections. The
recording pipettes contained (mmol/L) KCl 115, KOH 15, EGTA 10,
HEPES 10, and glucose 5 (pH 7.2, 300 to 310 mOsm). The bath solution
contained (mmol/L) NaCl 140, KCl 4, MgCl2 2,
CaCl2 1, HEPES 10, and glucose 5 (pH 7.4, 300 to
310 mOsm). Experiments were performed by using a Dagan model 3900
patch-clamp amplifier interfaced to an IBM-compatible 486 computer with
a Tecmar Labmaster-1 analog/digital interface (Axon Instruments) and
the pClamp 6 software package (Axon). Data were filtered at 5 kHz
before storage. Electrodes were fabricated from soda lime glass
(Kimble), coated with Sylgard (Dow Corning), and fire-polished; tip
resistances were 1.5 to 2.5 M
. Series resistances were in the range
of 3 to 4 M
and were compensated electronically by 80% to 90%;
voltage errors resulting from the uncompensated series resistance were
8 mV and were not corrected.
Recordings from isolated ventricular myocytes were
obtained at room temperature on the day of isolation. The
recording conditions were the same as those described above for
experiments on QT-6 cells, except as noted. For voltage-clamp
experiments, the bath solution routinely contained (mmol/L) NaCl 136,
KCl 4, CaCl2 1, MgCl2 2,
CoCl2 5, HEPES 10, glucose 10, and tetrodotoxin
0.02 (pH 7.4, 295 to 300 mOsm); tetrodotoxin and
Co2+ were eliminated when action potentials were
recorded. For both current- and voltage-clamp experiments, the
recording pipette solution contained (mmol/L) KCl 135, EGTA 10,
HEPES 10, and glucose 5 (pH 7.2, 295 to 310 mOsm). Outward
K+ currents were evoked during 200-ms or 3-s
depolarizing voltage steps to test potentials between -50 and +50 mV
from a holding potential of -70 mV after a 20-ms prepulse to -20 mV
(to eliminate the tetrodotoxin-insensitive voltage-gated
Na+ current). Inwardly rectifying
K+ current (IK1) was
evoked during hyperpolarizing voltage steps to test potentials between
-90 and -130 mV. Electrodes, fabricated as described above, had tip
resistances of 1.5 to 2.0 M
when filled with the standard
recording solution. Series resistances were in the range of 3
to 3.5 M
and were compensated electronically by 80% to 90%;
voltage errors resulting from the uncompensated series resistance were
always
6 mV and were not corrected.
Electrocardiograms
Surface ECGs were recorded from adult wild-type and
Kv4.2W362F-expressing mice by using methods similar to those previously
described.27 Briefly, mice were lightly
anesthetized with 3% halothane (97%
O2), and needle electrodes were placed on the
limbs under the skin. Standard ECG recordings were first
obtained from leads I, II, and III simultaneously at a
frequency response of 0.05 to 500 Hz with the use of a Gould model
13-4615 ECG amplifier (Gould Inc). The electrode normally on the left
arm was then moved to the back of the left shoulder, and the right arm
electrode was placed at the base of the sternum. In this configuration,
maximal amplitude recordings were obtained, facilitating the
resolution of the QT wave(s) and, therefore, allowing more accurate
measurements of QT intervals. Signals were digitized at 2 kHz and
recorded on a 486 personal computer.
Data Analysis
Voltage-clamp and current-clamp data were compiled and
analyzed using Clampfit (Axon Instruments) and Excel
(Microsoft). For each cell, the spatial control of the membrane voltage
was assessed by analyzing the decays of the capacitative transients
evoked during subthreshold ±10-mV voltage steps from the holding
potential (-70 mV); only cells with capacitative transients well
described by single exponentials were analyzed further.
Whole-cell ventricular myocyte membrane capacitances were
determined by integration of the capacitative transients evoked during
brief (25-ms) subthreshold (±10-mV) voltage steps from a holding
potential of -70 mV. The whole-cell membrane capacitances of cells
isolated from wild-type and transgenic animals were indistinguishable,
with mean±SEM values of 140±8 pF (n=20) and 152±9 pF (n=35) in
wild-type and Kv4.2W362F-expressing cells, respectively. The input
resistances of adult mouse wild-type (n=15) and Kv4.2W362F-expressing
(n=22) ventricular myocytes were also indistinguishable,
with mean±SEM values of 1.33±0.22 G
and 1.47±0.30 G
,
respectively. Leak currents were always <100 pA and were not
corrected. The plateau outward K+ current was
defined as the current remaining 3 s after the onset of the
depolarizing voltage steps, and the peak outward current was defined as
the maximum value of the outward K+ current
during 200-ms voltage steps. Current amplitudes, measured in individual
cells, were normalized for differences in cell size (whole-cell
membrane capacitance), and current densities (in pA/pF) are
reported.
The time constants of inactivation of the
depolarization-activated outward K+
currents in wild-type and Kv4.2W362F-expressing ventricular
myocytes were determined from double-exponential fits to the decay
phases of the current, using the following equation:
At=A1 ·
exp(-t/
1)+A2 ·
exp(-t/
2)+Ass,
where At is the amplitude of the current at time,
t; A1,
1,
A2, and
2
represent the amplitudes (A) and the time constants (
) of
the fast (subscript 1) and slow (subscript 2) components of current
decay; and Ass is the amplitude of the
noninactivating component of the total outward
K+ current. In some analyses, the decay
phases of the currents in wild-type ventricular myocytes
were (force) fitted by the sum of 3 exponentials with fixed time
constants (see Results). In this case, a third current component
(A3) with a decay time constant
(
3) of
200 ms was added; the values of
1 (Ito) and
2 (the slow current) were also fixed at
70
ms and
1000 ms, respectively (see Results). Correlation coefficients
were determined to assess the quality of the fits; in all cases,
correlation coefficients were
0.980. For analysis of ECGs,
the onsets and offsets of the P, Q, R, S, and T waves were determined
by measuring the earliest (onset) and the latest (offset) times from
the 3 leads. Measured QT intervals were corrected for differences in
heart rate using the formula,
QTc=QT/(RR/100)1/2, as described by London et
al.28 All data are presented as
mean±SEM. Differences between wild-type and Kv4.2W362F-expressing
myocytes were analyzed using ANOVA and the Student t
test; P values are presented in the text.
| Results |
|---|
|
|
|---|
-subunit expression
is readily detected in mouse ventricles by Western blot
analysis and by immunohistochemistry (data not shown), the
dominant-negative Kv4 subunit was tagged at the C-terminus with the 8
amino acid FLAG epitope to allow direct detection of expression of the
transgene (see Materials and Methods).
|
When transiently transfected into QT-6 cells, expression of Kv4.2W362F
was readily detected immunohistochemically using either an anti-Kv4.2
antibody or an anti-FLAG M2 antibody (data not shown). In whole-cell
voltage-clamp recordings from Kv4.2W362F-FLAGexpressing QT-6
cells, however, no outward K+ currents were
recorded (Figure 1b
), suggesting that the mutant Kv4 subunit forms
channels that are nonconducting. Furthermore, when equal amounts of the
plasmids encoding wild-type Kv4.2 and Kv4.2W362F-FLAG were
cotransfected into QT-6 cells, the densities of the Kv4.2-induced
currents are markedly reduced (Figure 1d
) compared with cells
expressing wild-type Kv4.2 alone (Figure 1c
). The mean±SEM peak
outward K+ current densities at +50 mV in
QT-6expressing wild-type Kv4.2 alone or wild-type Kv4.2 plus
Kv4.2W362F were 454±36 pA/pF (n=10) and 87±16 pA/pF (n=10),
respectively; these values are significantly (at the
P<0.001 level) different. However, the voltage dependences
and the rates of activation and inactivation of the Kv4.2-induced
currents in the absence and in the presence of Kv4.2W362F are
indistinguishable (n=10), indicating that assembly of wild-type
subunits with Kv4.2W362F leads to nonfunctional channels rather than to
channels with altered time- and/or voltage-dependent properties; ie,
Kv4.2W362F functions as a dominant
negative.21 22
Coexpression of Kv4.2W362F with another member of the Kv4 subfamily,
Kv4.3, also attenuates the K+ currents (Figure 1f
) produced on expression of Kv4.3 alone (Figure 1e
). The mean±SEM
peak outward K+ current density at +50 mV in
QT-6expressing wild-type Kv4.3 was 351±76 pA/pF (n=10), and no
outward K+ currents were recorded from cells
coexpressing wild-type Kv4.3 and Kv4.2W362F. However, coexpression of
Kv4.2W362F with Kv1.4, a member of the Shaker subfamily that
is not expected to assemble with subunits of the Kv4
subfamily,29 has no measurable effect on Kv1.4
currents (Figure 1g
and 1h
). The mean±SEM peak outward
K+ current densities at +50 mV in
QT-6expressing Kv1.4 alone or Kv1.4 plus Kv4.2W362F were 476±75
pA/pF (n=9) and 432±79 pA/pF (n=9), respectively; these values are not
significantly different.
Generation and Characterization of Transgenic Mice Expressing
Kv4.2W362F
The FLAG-tagged Kv4.2W362F DNA sequence was subcloned (see
Materials and Methods) downstream from the cardiac-specific
-MHC
promoter in the
-MHC expression vector (generously provided to us by
Dr Jeffery Robbins, University of Cincinnati, Cincinnati, Ohio).
Previous work has documented that this promoter is cardiac specific and
that constitutive expression of the
-MHC protein, as well as
transgenes driven by this promoter, are detected in atria and
ventricles from the time of birth.23 24 25 26 A 7-kb
fragment containing the
-MHC promoter, the Kv4.2W362F-FLAG sequence,
and the HGH polyadenylation signal sequence was isolated and injected
into fertilized mouse oocytes (see Materials and Methods). For
screening, genomic tail DNA was prepared, and transgene incorporation
was assayed by Southern blot analysis using a probe directed
against the HGH polyadenylation signal sequence (see Materials and
Methods). Three founders (Nos. 15, 25, and 27) were identified (data
not shown) and were bred to wild-type C57CBA mice to generate 3 lines
of Kv4.2W362F-FLAGexpressing transgenic mice. Initial
analysis of the functional consequences of Kv4.2W362F
expression were completed on the F1 progeny of founder No. 25. As
illustrated in Figure 2a
, Kv4.3W362F-FLAG
protein expression was readily detected in Western blots of
fractionated mouse ventricular membrane proteins prepared
from line 25 transgenic animals (Figure 2a
, arrow), whereas nothing is
detected in immunoblots of ventricular membrane
proteins prepared from wild-type littermates. In addition, the FLAG
epitope was readily detected immunohistochemically in isolated
ventricular myocytes from transgenic animals (Figure 2b
and 2c
), whereas no staining was observed in myocytes isolated from
nontransgenic littermates (Figure 2d
and 2e
).
|
On gross examination, there are no obvious differences between the Kv4.2W362F-expressing transgenic animals and their nontransgenic littermates. Mean±SEM body weights, for example, were 25.1±4.4 g (n=5) and 26.3±2.5 g (n=10) for 8-week (adult) wild-type and Kv4.2W362F-expressing animals; these values are not significantly different. Heart weights were also not significantly different, with mean±SEM values of 98±9 mg (n=5) and 102±7 mg (n=10) for wild-type and Kv4.2W362F-expressing animals, respectively. Heart weighttobody weight ratios in nontransgenic and transgenic animals were also very similar, and histological examination of hearts from Kv4.2W362F-expressing animals revealed no significant differences from control hearts. In addition, the input resistances and whole-cell membrane capacitances of ventricular myocytes isolated from Kv4.2W362F-expressing and wild-type animals are indistinguishable (see Materials and Methods).
Outward K+ Currents Are Altered in
Kv4.2W362F-Expressing Ventricular Myocytes
Whole-cell voltage-clamp recordings, however, revealed
marked differences in the waveforms of the
depolarization-activated outward K+
currents in ventricular myocytes isolated from wild-type
and transgenic littermates (Figure 3
). As
illustrated in Figure 3
, peak outward K+ current
amplitudes at all test potentials are substantially lower in cells
isolated from transgenic animals (Figure 3b
and 3d
) compared with the
currents typically recorded in myocytes isolated from wild-type
littermates (Figure 3a
and 3c
). Similar results were obtained in 40
myocytes from 2 Kv4.2W362F-FLAG transgenic animals derived from line
25, and the mean±SEM peak outward densities at +20 mV were 37.1±2.5
pA/pF (n=39) and 16.1±1.0 pA/pF (n=40) in wild-type and
Kv4.2W362F-expressing myocytes, respectively; these values are
significantly (at the P
0.001 level) different. In contrast
to the marked reductions in peak outward K+
current densities in ventricular myocytes isolated from the
Kv4.2W362F-expressing transgenic animals, no measurable effects on the
densities of either the plateau outward K+
currents, determined as the currents remaining at the end of 3-s
voltage steps, or of the
hyperpolarization-activated inwardly
rectifying K+ current,
IK1, were observed. Mean±SEM plateau
outward current densities at +20 mV, for example, were 3.5±0.4 pA/pF
(n=18) and 3.7±0.2 pA/pF (n=18) in wild-type and Kv4.2W362F-expressing
myocytes, respectively (Figure 4a
). Mean±SEM peak
IK1 densities evoked at -120 mV from a
holding potential of -70 mV in wild-type and Kv4.2W362F-expressing
myocytes were 11±0.5 pA/pF (n=19) and 12±0.5 pA/pF (n=18),
respectively (Figure 4a
).
|
|
Action Potentials and QT Intervals Are Prolonged in
Kv4.2W362F-Expressing Animals
In current-clamp experiments, action potentials recorded from
Kv4.2W362F-expressing isolated ventricular myocytes (Figure 3f
) are substantially broader than action potentials recorded from
cells isolated from nontransgenic littermates (Figure 3e
),
consistent with the elimination of
Ito. Analysis of action potential
durations at 90% repolarization revealed mean±SEM values of 36±10 ms
(n=9) and 116±14 ms (n=9) in wild-type and Kv4.2W362F-expressing
cells, respectively; these values are significantly (at the
P<0.001 level) different. In contrast, action potential
amplitudes and resting membrane potentials of the Kv4.2W362F-expressing
myocytes are not significantly different from those measured in
wild-type cells.
To determine the functional consequences of the marked prolongation of
ventricular action potentials, surface ECGs were
recorded from Kv4.2W362F-expressing transgenic and nontransgenic
littermates (Figure 5
). Analysis
of the ECGs revealed a marked prolongation of the QT interval in the
transgenic animals, consistent with the underlying defect being
in ventricular repolarization. Mean±SEM QT intervals in
wild-type and transgenic animals were found to equal 79±5 ms (n=5) and
121±5 ms (n=12), respectively; these values are significantly
different at the P<0.001 level. Neither heart rates (RR
intervals) nor QRS durations, however, were affected by Kv4.2W362F
expression. Mean±SEM RR intervals were 193±19 ms (n=5) and 250±23 ms
(n=12) in wild-type and Kv4.2W362F-expressing animals, respectively,
and mean±SEM QRS durations were 10.8±0.4 ms (n=5) and 11.2±0.2 ms
(n=12) in control and transgenic animals, respectively. When QT
intervals were corrected for heart rate,28 the
differences between the transgenic and the nontransgenic animals were
also highly significant (at the P<0.001 level): mean±SEM
QTc intervals (see Materials and Methods) were 57±3 ms (n=5) and 79±3
ms (n=12) in control and Kv4.2W262-expressing animals,
respectively.
|
Upregulation of a Novel Current in Kv4.2W362F-Expressing
Ventricular Myocytes
As is evident in Figure 3
, the waveforms of the
depolarization-activated K+ currents in
ventricular myocytes isolated from wild-type and
Kv4.2W362F-expressing littermates are distinct. Specifically, the fast
component of inactivation (attributed to
Ito30) appears to be
markedly reduced or eliminated in the Kv4.2W362F-expressing cells
(Figure 3b
and 3d
). Analysis of the decay phases of the
currents evoked during 3-s voltage steps confirmed this impression. For
wild-type myocytes, the decay phases of the peak outward currents were
well described by the sum of 2 exponentials with mean±SEM time
constants of 72±4 ms (n=18) and 956±45 ms (n=18); these values are
similar to those recently reported by Wang and
Duff30 (1997) and London et
al28 (1998). As also reported
previously,30 neither the fast nor the slow
component of peak outward current decay in wild-type cells displays any
appreciable voltage dependence (Figure 4b
). The decay phases of the
currents in Kv4.2W362F-expressing myocytes were also well described by
the sum of 2 exponentials. In this case, however, the mean±SEM decay
time constants were 212±19 ms (n=13) and 1140±85 ms (n=13), and
similar to the findings in wild-type cells, neither time constant
varies with voltage (Figure 4b
). Importantly, the very rapid component
of current decay in wild-type mouse ventricular myocytes
(
decay,
70 ms), which reflects
Ito,28 30 is not
evident in the transgenic cells (Figure 3b
and 3d
), consistent
with the "functional knockout" of Ito.
Similar results have been obtained in voltage-clamp experiments
completed on ventricular myocytes isolated from progeny of
transgenic founders 15 and 27; ie, Ito is
also functionally eliminated in these cells. The mean±SEM time
constants of inactivation of the slower components of current decay are
not significantly different, suggesting that the slow components of
current decay in wild-type (
decay, 956±45 ms)
and Kv4.2W362F-expressing (
decay, 1145±85 ms)
ventricular myocytes are the same. Interestingly, this
slowly inactivating K+ current is selectively
attenuated in transgenic mice28 expressing a
dominant-negative Kv1.1 construct,
Kv1.1N206Tag.31
Inactivation of the fast component of peak outward current decay
(mean±SEM
decay, 212±19 ms) in
Kv4.2W362F-expressing ventricular myocytes is significantly
(P
0.001) slower than Ito
(
decay,
70 ms) at all test potentials
(Figure 4b
). Because the experiments on QT-6 cells (Figure 1
) revealed
that coexpression of the Kv4.2W362F with wild-type Kv4
subunits
reduces K+ current amplitudes/densities without
changing the kinetic properties of the currents, it seems unlikely that
the fast component of current decay in Kv4.2W362F-expressing
ventricular myocytes reflects (modified)
Ito. Rather, the results suggest that in
the absence of Ito, a "novel"
inactivating current component is revealed, ie, a current that is not
evident in wild-type cells. It might also be suggested, however, that
eliminating the majority of Ito channels
reveals a current that is not apparent in wild-type cells, simply
because the density of this current is too low relative to
Ito to be resolved. The fact that the time
constants for inactivation of Ito
(
decay,
70 ms) and the novel current
(
decay,
200 ms) differ by less than a
factor of 3 would further complicate resolution of the 2 current
components. To test the hypothesis that the novel current might also be
present in wild-type cells, the decay phases of the currents were
fitted by the sum of 3 exponentials with fixed time constants of 70 ms
(for Ito), 200 ms (for the novel transgenic
current), and 1 s (for the slowly inactivating current).
As might be expected, these analyses revealed that the decay
phases of the currents could indeed be fitted by the sum of 3
exponentials, and the mean±SEM (n=10) densities of the current
components at +20 mV were as follows: 20.1±3.8 pA/pF for
Ito, 3.1±0.9 for the current with the
decay of
200 ms, and 15.8±1.3 pA/pF for
the slowly decaying K+ current. The density of
the novel current (
decay,
200 ms) predicted
by this analysis, therefore, is very low. In addition, the fits
suggest that this current component contributes 7±2% to the peak
outward current, whereas the Ito and the
slowly decaying currents contribute 44±4% and 34±3%, respectively,
to the peak current;
15% of the peak outward
K+ current is noninactivating
(Figure 3c
). In Kv4.2W362F-expressing ventricular myocytes,
however, the novel current contributes
50% to the peak outward
current, with a mean±SEM density of 8.3±0.6 pA/pF (n=10). Thus, even
if expressed in wild-type myocytes, the results demonstrate that the
novel current is markedly upregulated in Kv4.2W362F-expressing
myocytes. More important, however, is the fact that the quality of the
fits to the decay phases of the currents in wild-type cells was not
improved by the inclusion of the third component
(
decay,
200 ms). We suggest, therefore,
that there are 2 (not 3) inactivating components of the outward
K+ currents in wild-type myocytes,
Ito (mean±SEM
decay, 72±4 ms) and the slowly decaying
current (mean±SEM
decay, 956±45 ms), and we
further suggest that the current in the transgenic cells with the
mean±SEM
decay of 212±19 ms reflects a novel
current that is not expressed in wild-type cells (see Discussion).
| Discussion |
|---|
|
|
|---|
-subunit subfamily underlie
Ito in the mouse ventricle. The functional
knockout of Ito results in increased action
potential durations in single ventricular myocytes and
prolongation of the QT interval recorded in surface ECGs.
Therefore, it would seem reasonable to suggest that the Kv4.2W362F
transgenics could potentially provide a rational experimental model for
probing the molecular mechanisms underlying long-QT syndromes and other
cardiac arrhythmias. Interestingly, however, in spite of the
marked increases in action potential durations and QT intervals, the
expression of Kv4.2W362F does not appear to have profound
physiological or
pathophysiological consequences. In fact, the
Kv4.2W362F-expressing animals appear normal in every respect, and in
experiments completed to date, we find no evidence that these animals
are prone to develop arrhythmias. However, experiments aimed at
determining if there are experimental conditions (such as pacing and
adrenergic stimulation) that result in sustained arrhythmias in
Kv4.2W362F-expressing animals/hearts are certainly warranted. Recently, London et al28 reported the generation and characterization of long-QT mice expressing a truncated Kv1.1 subunit (Kv1.1N206Tag)31 that also functions as a dominant negative. Expression of the Kv1.1N206Tag selectively attenuates the slowly decaying component of the total depolarization-activated K+ current in mouse ventricular myocytes, consistent with the hypothesis that a member of the Kv1 subfamily, likely Kv1.5, underlies this (slowly inactivating) K+ current.28 32 Similar to the results presented here, cardiac-specific expression of Kv1.1N206Tag results in prolonged ventricular action potentials and QT intervals.28 Interestingly, however, and in contrast to the results reported in the present study, London et al28 also reported increased frequency of premature ventricular beats, ventricular arrhythmias, and spontaneous ventricular tachyarrhythmias in Kv1.1N206Tag-expressing mice. As noted above, however, the Kv4.2W362F-expressing animals do not have spontaneous ventricular arrhythmias. In addition, it is of interest to note that the increases in action potential durations observed in Kv4.2W362F-expressing ventricular myocytes and the QT prolongation in Kv4.2W362F-expressing animals are both larger those seen in the Kv1.1N206Tag-expressing transgenics.28 Taken together, these results suggest that factors in addition to prolonged ventricular repolarization play an important role in determining the propensity to develop and to sustain arrhythmias. Clearly, studies focused on exploring the molecular mechanisms underlying the markedly different phenotypes of Kv4.2W362F- and Kv1.1N206Tag-expressing mice are warranted.
Upregulation of a Novel Current in Kv4.2W362F-Expressing
Ventricular Myocytes
In addition to providing a direct link between
Ito and the Kv4 subfamily of
subunits,
the results of the present study demonstrate that a novel, rapidly
activating, slowly inactivating current component is revealed when
functional Ito channels are eliminated.
This intriguing finding suggests that the downregulation of one channel
type, in this case Ito, influences the
expression of other channel types, and preliminary experiments suggest
that the upregulation of a Kv
subunit that is not abundant in
wild-type animals underlies this novel K+
conductance pathway. Interestingly, previous studies have demonstrated
that Kv
-subunit message levels can change in response to a number
of physiological stimuli, including
cAMP,33 depolarization,33
dexamethasone,34 and
stress,34 suggesting that Kv
-subunit
expression in the heart might be highly regulated. With the use of the
Kv4.2W362F-expressing transgenic mice, it will now be possible to begin
to explore the molecular mechanism(s) underlying functional electrical
remodeling of the heart and to determine whether remodeling is
dependent on changes in the expression of specific ion channels
(Ito) and/or specific alterations in
cardiac electrical activity. Ongoing experiments are aimed at
determining the detailed time- and voltage-dependent properties, as
well as the pharmacological sensitivity, of the current that is
upregulated in the Kv4.2W362F-expressing animals. Experiments focused
on identifying the Kv
subunit(s) that underlies the novel
K+ current that is upregulated in
Kv4.2W362F-expressing animals have also been initiated.
| Acknowledgments |
|---|
-MHC transgenic
construct, Drs Jane Dixon and David McKinnon (State University of New
York at Stony Brook) for providing us with the Kv4.3 cDNA, and Drs
Morgan Sheng (Harvard University) and Lily Y. Jan (University of
California at San Francisco) for the Kv4.2 cDNA. Received April 20, 1998; accepted July 17, 1998.
| References |
|---|
|
|
|---|
2. Campbell DL, Rasmusson RL, Comer MB, Strauss HC. The cardiac calcium-independent transient outward potassium current: kinetics, molecular properties, and role in ventricular repolarization. In: Zipes DP, Jalife J, eds. Cardiac Electrophysiology: From Cell to Bedside. 2nd ed. Philadelphia, Pa: WB Saunders Co; 1995:8396.
3. Kass RS. Delayed potassium channels in the heart: cellular, molecular, and regulatory properties In: Zipes DP, Jalife J, eds. Cardiac Electrophysiology: From Cell to Bedside. 2nd ed. Philadelphia, Pa: WB Saunders Co; 1995:7482.
4. Potreau D, Gomez JP, Fares N. Depressed transient outward current in single hypertrophied cardiomyocytes isolated from the right ventricle of ferret heart. Cardiovasc Res. 1995;30:440448.[Medline] [Order article via Infotrieve]
5.
Gidh-Jain M, Huang B, Jain P, El-Sherif N.
Differential expression of voltage-gated K+
channel genes in left ventricular remodeled
myocardium after experimental myocardial infarction.
Circ Res. 1996;79:669675.
6.
Van Wagoner DR, Pond AL, McCarthy PM, Trimmer JS,
Nerbonne JM. Outward K+ current densities and
Kv1.5 expression are reduced in chronic human atrial fibrillation.
Circ Res. 1997;80:772781.
7. Wang Q, Curran ME, Splawski I, Burn TC, Millholland JM, VanRay TJ, Shen J, Timothy KW, Vincent GM, deJager T, Schwartz PJ, Toubin JA, Moss AJ, Atkinson DL, Landes GM, Connors TD, Keating MT. Positional cloning of a novel potassium channel gene: KvLQT1 mutations cause cardiac arrhythmias. Nat Genet. 1996;12:1723.[Medline] [Order article via Infotrieve]
8. Curran ME, Splawski I, Timothy KW, Vincent GM, Green ED, Keating MT. A molecular basis for cardiac arrhythmia: herg mutations cause long QT syndrome. Cell. 1995;80:795803.[Medline] [Order article via Infotrieve]
9. Sanguinetti MC, Jiang C, Curran ME, Keating MT. A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel. Cell. 1995;81:299307.[Medline] [Order article via Infotrieve]
10.
Trudeau MC, Warmke JW, Ganetzky B, Robertson, GA. HERG,
a human inward rectifier in the voltage-gated potassium channel family.
Science. 1995;269:9295.
11. Barhanin J, Lesage F, Guillemare E, Fink M, Lazdunski M, Romey G. KvLQT1 and IsK (minK) proteins associate to form the IKs cardiac potassium current. Nature. 1996;384:7880.[Medline] [Order article via Infotrieve]
12. Sanguinetti MC, Curran ME, Zou A, Shen J, Spector PS, Atkinson DL, Keating MT. Coassembly of KvLQT1 and minK (IsK) proteins to form cardiac IKs potassium channel. Nature. 1996;384:8083.[Medline] [Order article via Infotrieve]
13.
Dixon JE, McKinnon D. Quantitative analysis of
potassium channel mRNA expression in atrial and ventricular
muscle of rats. Circ Res. 1994;75:252260.
14.
Barry DM, Trimmer JS, Merlie JP, Nerbonne JM.
Differential expression of voltage-gated K+
channel subunits in adult rat heart: relationship to functional
K+ channels? Circ Res. 1995;77:361369.
15.
Dixon JE, Shi W, Wang H-S, McDonald C, Yu H, Wymore RS,
Cohen IS, McKinnon D. Role of the Kv4.3 K+
channel in ventricular muscle: a molecular correlate for
the transient outward current. Circ Res. 1996;79:659668.
16.
Xu H, Dixon JE, Barry DM, Trimmer JS, Merlie JP,
McKinnon D, Nerbonne JM. Developmental analysis reveals
mismatches in the expression of K+ channel
subunits and voltage-gated K+ channel currents in
rat ventricular myocytes. J Gen Physiol. 1996;108:405419.
17.
Fiset C, Clark RB, Shimoni Y, Giles WR. Shal-type
channels contribute to the Ca2+-independent
transient outward K+ current in rat ventricle.
J Physiol (Lond). 1997;500:5164.
18.
Sanguinetti MC, Johnson JH, Hammerland LG, Kelbaugh PR,
Volkmann RA, Saccomano NA, Mueller AL. Heteropodatoxins: peptides
isolated from spider venom that block Kv4.2 potassium channels.
Mol Pharmacol. 1997;51:491498.
19.
Po S, Roberds S, Snyders DJ, Tamkun MM, Bennett PB.
Heteromultimeric assembly of human potassium
channels: molecular basis of a transient outward current? Circ
Res. 1993;72:13261336.
20.
Murray KT, Fahrig SA, Deal KK, Po SS, Hu NN, Snyders
DJ, Tamkun MM, Bennett PB. Modulation of an inactivating human cardiac
K+ channel by protein kinase C. Circ
Res. 1994;75:9991005.
21. Perozo E, MacKinnon R, Benzanilla F, Stefani E. Gating currents from a nonconducting mutant reveal open-closed conformations in Shaker K+ channels. Neuron. 1993;11:353358.[Medline] [Order article via Infotrieve]
22.
Ribera AB. Homogeneous development of
electrical excitability via heterogeneous ion channel
expression. J Neurosci. 1996;16:11231130.
23.
Lyons GE, Schiaffino S, Sasson D, Barton P, Buckingham
M. Developmental regulation of myosin gene expression in mouse cardiac
muscle. J Cell Biol. 1990;111:24272436.
24.
Ng WA, Grupp IL, Subramaniam A, Robbins J. Cardiac
myosin heavy chain mRNA expression and myocardial function in the mouse
heart. Circ Res. 1991;68:17421750.
25.
Koch WJ, Rockman HA, Samama P, Hamilton RA, Bond RA,
Milano CA, Lefkowitz RJ. Cardiac function in mice overexpressing
the ß-adrenergic receptor kinase or a ßARK
inhibitor. Science. 1995;268:13501352.
26.
Palermo J, Gulick J, Colbert M, Fewell J, Robbins J.
Transgenic remodeling of the contractile apparatus in the
mammalian heart. Circ Res. 1996;78:504509.
27. Guerrero PA, Schuessler RB, Davis LM, Beyer EC, Johnson CM, Yamada KA, Saffitz JE. Slow ventricular conduction in mice heterozygous for a connexin 43 null mutation. J Clin Invest. 1997;99:19911998.[Medline] [Order article via Infotrieve]
28.
London B, Jeron A, Zhou J, Buckett P, Han X, Mitchell
GF, Koren G. Long QT and ventricular arrhythmias in
transgenic mice expressing the N terminus and first transmembrane
segment of a voltage-gated potassium channel. Proc Natl Acad Sci
U S A. 1998;95:29262931.
29. Covarrubias M, Wei A, Salkoff L. Shaker, Shal, Shab, and Shaw express independent K+ current systems. Neuron. 1991;7:763773.[Medline] [Order article via Infotrieve]
30.
Wang L, Duff HJ. Developmental changes in transient
outward current in mouse ventricle. Circ Res. 1997;81:120127.
31.
Folco E, Mathur R, Mori Y, Buckett P, Koren G. A
cellular model for long QT syndrome: trapping of
heteromultimeric complexes consisting of truncated
Kv1.1 potassium channel polypeptides and native Kv1.4 and Kv1.5
channels in the endoplasmic reticulum. J Biol Chem. 1997;272:2650526510.
32.
Fiset C, Clark RB, Larsen TS, Giles WR. A rapidly
activating, sustained current modulates repolarization and
excitation-contraction coupling in adult mouse ventricle. J
Physiol (Lond). 1997;504:557563.
33.
Mori Y, Matsubara H, Folco E, Siegal A, Koren G. The
transcription of a mammalian voltage-gated potassium channel is
regulated by cAMP in a cell-specific manner. J Biol
Chem.. 1993;268:2648226493.
34. Levitan ES, Hershman KM, Sherman TG, Takimoto K. Dexamethasone and stress upregulate Kv1.5 K+ channel gene expression in rat ventricular myocytes. Neuropharmacology. 1996;35:10011006.[Medline] [Order article via Infotrieve]
This article has been cited by other articles:
![]() |
K. Rivard, V. Trepanier-Boulay, H. Rindt, and C. Fiset Electrical remodeling in a transgenic mouse model of {alpha}1B-adrenergic receptor overexpression Am J Physiol Heart Circ Physiol, March 1, 2009; 296(3): H704 - H718. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. K. Roepke, A. Kontogeorgis, C. Ovanez, X. Xu, J. B. Young, K. Purtell, P. A. Goldstein, D. J. Christini, N. S. Peters, F. G. Akar, et al. Targeted deletion of kcne2 impairs ventricular repolarization via disruption of IK,slow1 and Ito,f FASEB J, October 1, 2008; 22(10): 3648 - 3660. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Colinas, F. D. Perez-Carretero, J. R. Lopez-Lopez, and M. T. Perez-Garcia A Role for DPPX Modulating External TEA Sensitivity of Kv4 Channels J. Gen. Physiol., May 1, 2008; 131(5): 455 - 471. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Rivard, P. Paradis, M. Nemer, and C. Fiset Cardiac-specific overexpression of the human type 1 angiotensin II receptor causes delayed repolarization Cardiovasc Res, April 1, 2008; 78(1): 53 - 62. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Grandy, V. Trepanier-Boulay, and C. Fiset Postnatal development has a marked effect on ventricular repolarization in mice Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2168 - H2177. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Goltz, J.-H. Schultz, C. Stucke, M. Wagner, P. Bassalay, A. P. Schwoerer, H. Ehmke, and T. Volk Diminished Kv4.2/3 but not KChIP2 levels reduce the cardiac transient outward K+ current in spontaneously hypertensive rats Cardiovasc Res, April 1, 2007; 74(1): 85 - 95. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Bourdeau, F. Morin, C. E. Laurent, M. Azzi, and J.-C. Lacaille Kv4.3-Mediated A-Type K+ Currents Underlie Rhythmic Activity in Hippocampal Interneurons J. Neurosci., February 21, 2007; 27(8): 1942 - 1953. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Salama and B. London Mouse models of long QT syndrome J. Physiol., January 1, 2007; 578(1): 43 - 53. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. London, L. C. Baker, P. Petkova-Kirova, J. M. Nerbonne, B.-R. Choi, and G. Salama Dispersion of repolarization and refractoriness are determinants of arrhythmia phenotype in transgenic mice with long QT J. Physiol., January 1, 2007; 578(1): 115 - 129. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. L. Fawcett, C. M. Santi, A. Butler, T. Harris, M. Covarrubias, and L. Salkoff Mutant Analysis of the Shal (Kv4) Voltage-gated Fast Transient K+ Channel in Caenorhabditis elegans J. Biol. Chem., October 13, 2006; 281(41): 30725 - 30735. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Han, S. Nattel, T. Noguchi, and A. Shrier C-terminal Domain of Kv4.2 and Associated KChIP2 Interactions Regulate Functional Expression and Gating of Kv4.2 J. Biol. Chem., September 15, 2006; 281(37): 27134 - 27144. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Dong, X. Sun, A. A. Prinz, and H.-S. Wang Effect of simulated Ito on guinea pig and canine ventricular action potential morphology Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H631 - H637. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. F. Rossow, K. W. Dilly, and L. F. Santana Differential Calcineurin/NFATc3 Activity Contributes to the Ito Transmural Gradient in the Mouse Heart Circ. Res., May 26, 2006; 98(10): 1306 - 1313. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. Petkova-Kirova, E. Gursoy, H. Mehdi, C. F. McTiernan, B. London, and G. Salama Electrical remodeling of cardiac myocytes from mice with heart failure due to the overexpression of tumor necrosis factor-{alpha} Am J Physiol Heart Circ Physiol, May 1, 2006; 290(5): H2098 - H2107. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wang, J. Cheng, R. W. Joyner, M. B. Wagner, and J. A. Hill Remodeling of Early-Phase Repolarization: A Mechanism of Abnormal Impulse Conduction in Heart Failure Circulation, April 18, 2006; 113(15): 1849 - 1856. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Jia and K. Takimoto Mitogen-Activated Protein Kinases Control Cardiac KChIP2 Gene Expression Circ. Res., February 17, 2006; 98(3): 386 - 393. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Guo, W. E. Jung, C. Marionneau, F. Aimond, H. Xu, K. A. Yamada, T. L. Schwarz, S. Demolombe, and J. M. Nerbonne Targeted Deletion of Kv4.2 Eliminates Ito,f and Results in Electrical and Molecular Remodeling, With No Evidence of Ventricular Hypertrophy or Myocardial Dysfunction Circ. Res., December 9, 2005; 97(12): 1342 - 1350. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Patel and D. L. Campbell Transient outward potassium current, 'Ito', phenotypes in the mammalian left ventricle: underlying molecular, cellular and biophysical mechanisms J. Physiol., November 15, 2005; 569(1): 7 - 39. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kim, D.-S. Wei, and D. A. Hoffman Kv4 potassium channel subunits control action potential repolarization and frequency-dependent broadening in rat hippocampal CA1 pyramidal neurones J. Physiol., November 15, 2005; 569(1): 41 - 57. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.-L. Wang, G.-X. Wang, S. Yamamoto, L. Ye, H. Baxter, J. R Hume, and D. Duan Molecular mechanisms of regulation of fast-inactivating voltage-dependent transient outward K+ current in mouse heart by cell volume changes J. Physiol., October 15, 2005; 568(2): 423 - 443. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Yuan, A. Burkhalter, and J. M. Nerbonne Functional Role of the Fast Transient Outward K+ Current IA in Pyramidal Neurons in (Rat) Primary Visual Cortex J. Neurosci., October 5, 2005; 25(40): 9185 - 9194. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Nerbonne and R. S. Kass Molecular Physiology of Cardiac Repolarization Physiol Rev, October 1, 2005; 85(4): 1205 - 1253. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Eghbali, R. Deva, A. Alioua, T. Y. Minosyan, H. Ruan, Y. Wang, L. Toro, and E. Stefani Molecular and Functional Signature of Heart Hypertrophy During Pregnancy Circ. Res., June 10, 2005; 96(11): 1208 - 1216. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Aimond, S. P. Kwak, K. J. Rhodes, and J. M. Nerbonne Accessory Kv{beta}1 Subunits Differentially Modulate the Functional Expression of Voltage-Gated K+ Channels in Mouse Ventricular Myocytes Circ. Res., March 4, 2005; 96(4): 451 - 458. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Xu, Z. Zhang, V. Timofeyev, D. Sharma, D. Xu, D. Tuteja, P. H. Dong, G. U. Ahmmed, Y. Ji, G. E Shull, et al. The effects of intracellular Ca2+ on cardiac K+ channel expression and activity: novel insights from genetically altered mice J. Physiol., February 1, 2005; 562(3): 745 - 758. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. P. Sergeant, S. Ohya, J. A. Reihill, B. A. Perrino, G. C. Amberg, Y. Imaizumi, B. Horowitz, K. M. Sanders, and S. D. Koh Regulation of Kv4.3 currents by Ca2+/calmodulin-dependent protein kinase II Am J Physiol Cell Physiol, February 1, 2005; 288(2): C304 - C313. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. V. Tranquillo, J. Hlavacek, and C. S. Henriquez An integrative model of mouse cardiac electrophysiology from cell to torso Europace, January 1, 2005; 7(s2): S56 - S70. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Li, M. McLerie, and A. N. Lopatin Transgenic upregulation of IK1 in the mouse heart leads to multiple abnormalities of cardiac excitability Am J Physiol Heart Circ Physiol, December 1, 2004; 287(6): H2790 - H2802. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Trepanier-Boulay, M.-A. Lupien, C. St-Michel, and C. Fiset Postnatal development of atrial repolarization in the mouse Cardiovasc Res, October 1, 2004; 64(1): 84 - 93. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Brouillette, R. B. Clark, W. R. Giles, and C. Fiset Functional properties of K+ currents in adult mouse ventricular myocytes J. Physiol., September 15, 2004; 559(3): 777 - 798. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Dun, S. Baba, T. Yagi, and P. A. Boyden Dynamic remodeling of K+ and Ca2+ currents in cells that survived in the epicardial border zone of canine healed infarcted heart Am J Physiol Heart Circ Physiol, September 1, 2004; 287(3): H1046 - H1054. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. E. Bondarenko, G. P. Szigeti, G. C. L. Bett, S.-J. Kim, and R. L. Rasmusson Computer model of action potential of mouse ventricular myocytes Am J Physiol Heart Circ Physiol, September 1, 2004; 287(3): H1378 - H1403. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Brunet, F. Aimond, H. Li, W. Guo, J. Eldstrom, D. Fedida, K. A. Yamada, and J. M. Nerbonne Heterogeneous expression of repolarizing, voltage-gated K+ currents in adult mouse ventricles J. Physiol., August 15, 2004; 559(1): 103 - 120. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Birnbaum, A. W. Varga, L.-L. Yuan, A. E. Anderson, J. D. Sweatt, and L. A. Schrader Structure and Function of Kv4-Family Transient Potassium Channels Physiol Rev, July 1, 2004; 84(3): 803 - 833. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-G. Lai, J. Yang, S.-S. Zhou, J. Zhu, G.-R. Li, and T.-M. Wong Involvement of anion channel(s) in the modulation of the transient outward K+ channel in rat ventricular myocytes Am J Physiol Cell Physiol, July 1, 2004; 287(1): C163 - C170. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Rosati and D. McKinnon Regulation of Ion Channel Expression Circ. Res., April 16, 2004; 94(7): 874 - 883. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Liu, J. B. Iden, K. Kovithavongs, R. Gulamhusein, H. J. Duff, and K. M. Kavanagh In vivo temporal and spatial distribution of depolarization and repolarization and the illusive murine T wave J. Physiol., February 15, 2004; 555(1): 267 - 279. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Kodirov, M. Brunner, J. M. Nerbonne, P. Buckett, G. F. Mitchell, and G. Koren Attenuation of IK,slow1 and IK,slow2 in Kv1/Kv2DN mice prolongs APD and QT intervals but does not suppress spontaneous or inducible arrhythmias Am J Physiol Heart Circ Physiol, January 1, 2004; 286(1): H368 - H374. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Li, W. Guo, K. A. Yamada, and J. M. Nerbonne Selective elimination of IK,slow1 in mouse ventricular myocytes expressing a dominant negative Kv1.5{alpha} subunit Am J Physiol Heart Circ Physiol, January 1, 2004; 286(1): H319 - H328. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Dun, P. Chandra, P. Danilo Jr., M. R. Rosen, and P. A. Boyden Chronic atrial fibrillation does not further decrease outward currents. It increases them. Am J Physiol Heart Circ Physiol, October 1, 2003; 285(4): H1378 - H1384. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Shibata, H. Misonou, C. R. Campomanes, A. E. Anderson, L. A. Schrader, L. C. Doliveira, K. I. Carroll, J. D. Sweatt, K. J. Rhodes, and J. S. Trimmer A Fundamental Role for KChIPs in Determining the Molecular Properties and Trafficking of Kv4.2 Potassium Channels J. Biol. Chem., September 19, 2003; 278(38): 36445 - 36454. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Bodi, J. N. Muth, H. S. Hahn, N. N. Petrashevskaya, M. Rubio, S. E. Koch, G. Varadi, and A. Schwartz Electrical remodeling in hearts from a calcium-dependent mouse model of hypertrophy and failure: Complex nature of k+ current changes and action potential duration J. Am. Coll. Cardiol., May 7, 2003; 41(9): 1611 - 1622. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. C. Amberg, S. D. Koh, Y. Imaizumi, S. Ohya, and K. M. Sanders A-type potassium currents in smooth muscle Am J Physiol Cell Physiol, March 1, 2003; 284(3): C583 - C595. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Bouter, S. Demolombe, A. Chambellan, C. Bellocq, F. Aimond, G. Toumaniantz, G. Lande, S. Siavoshian, I. Baro, A. L. Pond, et al. Microarray Analysis Reveals Complex Remodeling of Cardiac Ion Channel Expression With Altered Thyroid Status: Relation to Cellular and Integrated Electrophysiology Circ. Res., February 7, 2003; 92(2): 234 - 242. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zhou, S. Kodirov, M. Murata, P. D. Buckett, J. M. Nerbonne, and G. Koren Regional upregulation of Kv2.1-encoded current, IK,slow2, in Kv1DN mice is abolished by crossbreeding with Kv2DN mice Am J Physiol Heart Circ Physiol, February 1, 2003; 284(2): H491 - H500. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Dong, Y. Duan, J. Guo, D. E Roach, S. L Swirp, L. Wang, J.P Lees-Miller, R.S Sheldon, J. D Molkentin, and H. J Duff Overexpression of calcineurin in mouse causes sudden cardiac death associated with decreased density of K+ channels Cardiovasc Res, February 1, 2003; 57(2): 320 - 332. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Brouillette, V. Trepanier-Boulay, and C. Fiset Effect of androgen deficiency on mouse ventricular repolarization J. Physiol., January 15, 2003; 546(2): 403 - 413. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Chiello Tracy, C. Cabo, J. Coromilas, J. Kurokawa, R. S. Kass, and A. L. Wit Electrophysiological consequences of human IKs channel expression in adult murine heart Am J Physiol Heart Circ Physiol, January 1, 2003; 284(1): H168 - H175. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Malin and J. M. Nerbonne Delayed Rectifier K+ Currents, IK, Are Encoded by Kv2 alpha -Subunits and Regulate Tonic Firing in Mammalian Sympathetic Neurons J. Neurosci., December 1, 2002; 22(23): 10094 - 10105. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Zobel, Z. Kassiri, T.-T. T. Nguyen, Y. Meng, and P. H. Backx Prevention of Hypertrophy by Overexpression of Kv4.2 in Cultured Neonatal Cardiomyocytes Circulation, October 29, 2002; 106(18): 2385 - 2391. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Sacco and F. Tempia A-Type potassium currents active at subthreshold potentials in mouse cerebellar purkinje cells J. Physiol., September 1, 2002; 543(2): 505 - 520. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Guo, S. A. Malin, D. C. Johns, A. Jeromin, and J. M. Nerbonne Modulation of Kv4-encoded K+ Currents in the Mammalian Myocardium by Neuronal Calcium Sensor-1 J. Biol. Chem., July 12, 2002; 277(29): 26436 - 26443. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Escoubas, S. Diochot, M.-L. Celerier, T. Nakajima, and M. Lazdunski Novel Tarantula Toxins for Subtypes of Voltage-Dependent Potassium Channels in the Kv2 and Kv4 Subfamilies Mol. Pharmacol., July 1, 2002; 62(1): 48 - 57. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Danik, C. Cabo, C. Chiello, S. Kang, A. L. Wit, and J. Coromilas Correlation of repolarization of ventricular monophasic action potential with ECG in the murine heart Am J Physiol Heart Circ Physiol, July 1, 2002; 283(1): H372 - H381. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. B Walsh and G. E Parks Changes in cardiac myocyte morphology alter the properties of voltage-gated ion channels Cardiovasc Res, July 1, 2002; 55(1): 64 - 75. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A Lazaroff, A. D Taylor, and A. B Ribera In vivo analysis of Kv{beta}2 function in Xenopus embryonic myocytes J. Physiol., June 15, 2002; 541(3): 673 - 683. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. N Petrashevskaya, I. Bodi, M. Rubio, J. D Molkentin, and A. Schwartz Cardiac function and electrical remodeling of the calcineurin-overexpressed transgenic mouse Cardiovasc Res, April 1, 2002; 54(1): 117 - 132. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Sanguinetti Reduced Transient Outward K+ Current and Cardiac Hypertrophy: Causal Relationship or Epiphenomenon? Circ. Res., March 22, 2002; 90(5): 497 - 499. [Full Text] [PDF] |
||||
![]() |
Z. Kassiri, C. Zobel, T.-T. T. Nguyen, J. D. Molkentin, and P. H. Backx Reduction of Ito Causes Hypertrophy in Neonatal Rat Ventricular Myocytes Circ. Res., March 22, 2002; 90(5): 578 - 585. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Guo, H. Li, F. Aimond, D. C. Johns, K. J. Rhodes, J. S. Trimmer, and J. M. Nerbonne Role of Heteromultimers in the Generation of Myocardial Transient Outward K+ Currents Circ. Res., March 22, 2002; 90(5): 586 - 593. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wu and M. E Anderson Reduced repolarization reserve in ventricular myocytes from female mice Cardiovasc Res, February 15, 2002; 53(3): 763 - 769. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Holmqvist, J. Cao, R. Hernandez-Pineda, M. D. Jacobson, K. I. Carroll, M. A. Sung, M. Betty, P. Ge, K. J. Gilbride, M. E. Brown, et al. Elimination of fast inactivation in Kv4 A-type potassium channels by an auxiliary subunit domain PNAS, January 22, 2002; 99(2): 1035 - 1040. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S Nadal, Y. Amarillo, E. V.-S. de Miera, and B. Rudy Evidence for the presence of a novel Kv4-mediated A-type K+ channel-modifying factor J. Physiol., December 15, 2001; 537(3): 801 - 809. [Abstract] [Full Text] [PDF] |
||||
![]() |
Members of the Sicilian Gambit New Approaches to Antiarrhythmic Therapy, Part I: Emerging Therapeutic Applications of the Cell Biology of Cardiac Arrhythmias Circulation, December 4, 2001; 104(23): 2865 - 2873. [Abstract] [Full Text] [PDF] |
||||
![]() |
Members of the Sicilian Gambit New approaches to antiarrhythmic therapy; emerging therapeutic applications of the cell biology of cardiac arrhythmias Eur. Heart J., December 1, 2001; 22(23): 2148 - 2163. [Abstract] [PDF] |
||||
![]() |
Members of the Sicilian Gambit New approaches to antiarrhythmic therapy: emerging therapeutic applications of the cell biology of cardiac arrhythmias Cardiovasc Res, December 1, 2001; 52(3): 345 - 360. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Nerbonne, C. G. Nichols, T. L. Schwarz, and D. Escande Genetic Manipulation of Cardiac K+ Channel Function in Mice: What Have We Learned, and Where Do We Go From Here? Circ. Res., November 23, 2001; 89(11): 944 - 956. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Li, W. Guo, H. Xu, R. Hood, A. T. Benedict, and J. M. Nerbonne Functional expression of a GFP-tagged Kv1.5 alpha -subunit in mouse ventricle Am J Physiol Heart Circ Physiol, November 1, 2001; 281(5): H1955 - H1967. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Decher, O. Uyguner, C. R Scherer, B. Karaman, M. Yuksel-Apak, A. E Busch, K. Steinmeyer, and B. Wollnik hKChIP2 is a functional modifier of hKv4.3 potassium channels: Cloning and expression of a short hKChIP2 splice variant Cardiovasc Res, November 1, 2001; 52(2): 255 - 264. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Malin and J. M. Nerbonne Molecular Heterogeneity of the Voltage-Gated Fast Transient Outward K+ Current, IAf, in Mammalian Neurons J. Neurosci., October 15, 2001; 21(20): 8004 - 8014. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Wang, W. Kutschke, K. E. Richardson, M. Karimi, and J. A. Hill Electrical Remodeling in Pressure-Overload Cardiac Hypertrophy: Role of Calcineurin Circulation, October 2, 2001; 104(14): 1657 - 1663. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Brunner, W. Guo, G. F. Mitchell, P. D. Buckett, J. M. Nerbonne, and G. Koren Characterization of mice with a combined suppression of Ito and IK,slow Am J Physiol Heart Circ Physiol, September 1, 2001; 281(3): H1201 - H1209. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Cavero and W. Crumb Native and cloned ion channels from human heart: laboratory models for evaluating the cardiac safety of new drugs Eur. Heart J. Suppl., September 1, 2001; 3(suppl_K): K53 - K63. [Abstract] [PDF] |
||||
![]() |
M. J. Hernandez-Benito, R. Macianskiene, K. R. Sipido, W. Flameng, and K. Mubagwa Suppression of Transient Outward Potassium Currents in Mouse Ventricular Myocytes by Imidazole Antimycotics and by Glybenclamide J. Pharmacol. Exp. Ther., August 1, 2001; 298(2): 598 - 606. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Ufret-Vincenty, D. J. Baro, and L. F. Santana Differential contribution of sialic acid to the function of repolarizing K+ currents in ventricular myocytes Am J Physiol Cell Physiol, August 1, 2001; 281(2): C464 - C474. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Holmqvist, J. Cao, M. H. Knoppers, M. E. Jurman, P. S. Distefano, K. J. Rhodes, Y. Xie, and W. F. An Kinetic Modulation of Kv4-Mediated A-Current by Arachidonic Acid Is Dependent on Potassium Channel Interacting Proteins J. Neurosci., June 15, 2001; 21(12): 4154 - 4161. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J Zaritsky, J. B Redell, B. L Tempel, and T. L Schwarz The consequences of disrupting cardiac inwardly rectifying K+ current (IK1) as revealed by the targeted deletion of the murine Kir2.1 and Kir2.2 genes J. Physiol., June 15, 2001; 533(3): 697 - 710. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A Li, J. Miake, U. C Hoppe, D. C Johns, E. Marban, and H B. Nuss Functional consequences of the arrhythmogenic G306R KvLQT1 K+ channel mutant probed by viral gene transfer in cardiomyocytes J. Physiol., May 15, 2001; 533(1): 127 - 133. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Demolombe, G. Lande, F. Charpentier, M. A van Roon, M. J.B van den Hoff, G. Toumaniantz, I. Baro, G. Guihard, N. Le Berre, A. Corbier, et al. Transgenic mice overexpressing human KvLQT1 dominant-negative isoform Part I: Phenotypic characterisation Cardiovasc Res, May 1, 2001; 50(2): 314 - 327. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Lande, S. Demolombe, A. Bammert, A. Moorman, F. Charpentier, and D. Escande Transgenic mice overexpressing human KvLQT1 dominant-negative isoform Part II: Pharmacological profile Cardiovasc Res, May 1, 2001; 50(2): 328 - 334. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. C. Hoppe, E. Marban, and D. C. Johns Distinct gene-specific mechanisms of arrhythmia revealed by cardiac gene transfer of two long QT disease genes, HERG and KCNE1 PNAS, April 24, 2001; 98(9): 5335 - 5340. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-T. Zhang, K. Takimoto, A. F. R. Stewart, C. Zhu, and E. S. Levitan Independent Regulation of Cardiac Kv4.3 Potassium Channel Expression by Angiotensin II and Phenylephrine Circ. Res., March 16, 2001; 88(5): 476 - 482. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Bou-Abboud, H. Li, and J. M Nerbonne Molecular diversity of the repolarizing voltage-gated K+ currents in mouse atrial cells J. Physiol., December 1, 2000; 529(2): 345 - 358. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Greenstein, R. Wu, S. Po, G. F. Tomaselli, and R. L. Winslow Role of the Calcium-Independent Transient Outward Current Ito1 in Shaping Action Potential Morphology and Duration Circ. Res., November 24, 2000; 87(11): 1026 - 1033. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Thomas, L. Bircher-Lehmann, S. A. Thomas, J. Zhuang, J. E. Saffitz, and A. G. Kleber Synthetic Strands of Neonatal Mouse Cardiac Myocytes : Structural and Electrophysiological Properties Circ. Res., September 15, 2000; 87(6): 467 - 473. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. W. Varga, A. E. Anderson, J. P. Adams, H. Vogel, and J. D. Sweatt Input-Specific Immunolocalization of Differentially Phosphorylated Kv4.2 in the Mouse Brain Learn. Mem., September 1, 2000; 7(5): 321 - 332. [Abstract] [Full Text] |
||||
![]() |
M. T. Perez-Garcia, J. R. Lopez-Lopez, A. M. Riesco, U. C. Hoppe, E. Marban, C. Gonzalez, and D. C. Johns Viral Gene Transfer of Dominant-Negative Kv4 Construct Suppresses an O2-Sensitive K+ Current in Chemoreceptor Cells J. Neurosci., August 1, 2000; 20(15): 5689 - 5695. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Han, Z. Wang, and S. Nattel A comparison of transient outward currents in canine cardiac Purkinje cells and ventricular myocytes Am J Physiol Heart Circ Physiol, August 1, 2000; 279(2): H466 - H474. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Malin and J. M. Nerbonne Elimination of the Fast Transient in Superior Cervical Ganglion Neurons with Expression of KV4.2W362F: Molecular Dissection of IA J. Neurosci., July 15, 2000; 20(14): 5191 - 5199. [Abstract] [Full Text] [PDF] |
||||
![]() |
T W Claydon, M R Boyett, A Sivaprasadarao, K Ishii, J M Owen, H A O'Beirne, R Leach, K Komukai, and C H Orchard Inhibition of the K+ channel Kv1.4 by acidosis: protonation of an extracellular histidine slows the recovery from N-type inactivation J. Physiol., July 15, 2000; 526(2): 253 - 264. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Guo, H. Li, B. London, and J. M. Nerbonne Functional Consequences of Elimination of Ito, f and Ito, s : Early Afterdepolarizations, Atrioventricular Block, and Ventricular Arrhythmias in Mice Lacking Kv1.4 and Expressing a Dominant-Negative Kv4 {alpha} Subunit Circ. Res., July 7, 2000; 87(1): 73 - 79. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M Nerbonne Molecular basis of functional voltage-gated K+ channel diversity in the mammalian myocardium J. Physiol., June 1, 2000; 525(2): 285 - 298. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. C Knollmann, B. E C Knollmann-Ritschel, N. J Weissman, L. R Jones, and M. Morad Remodelling of ionic currents in hypertrophied and failing hearts of transgenic mice overexpressing calsequestrin J. Physiol., June 1, 2000; 525(2): 483 - 498. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Jeron, G. F. Mitchell, J. Zhou, M. Murata, B. London, P. Buckett, S. D. Wiviott, and G. Koren Inducible polymorphic ventricular tachyarrhythmias in a transgenic mouse model with a long Q-T phenotype Am J Physiol Heart Circ Physiol, June 1, 2000; 278(6): H1891 - H1898. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. James, A. Sanbe, K. Yager, L. Martin, R. Klevitsky, and J. Robbins Genetic Manipulation of the Rabbit Heart via Transgenesis Circulation, April 11, 2000; 101(14): 1715 - 1721. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. C. Baker, B. London, B.-R. Choi, G. Koren, and G. Salama Enhanced Dispersion of Repolarization and Refractoriness in Transgenic Mouse Hearts Promotes Reentrant Ventricular Tachycardia Circ. Res., March 3, 2000; 86(4): 396 - 407. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. S. Chauhan, S. Tuvia, M. Buhusi, V. Bennett, and A. O. Grant Abnormal Cardiac Na+ Channel Properties and QT Heart Rate Adaptation in Neonatal AnkyrinB Knockout Mice Circ. Res., March 3, 2000; 86(4): 441 - 447. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. H. DuBell, W. J. Lederer, and T. B. Rogers K+ currents responsible for repolarization in mouse ventricle and their modulation by FK-506 and rapamycin Am J Physiol Heart Circ Physiol, March 1, 2000; 278(3): H886 - H897. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1998 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |